Southborough, MA, United States of America

Jun Xian

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Evopoint Biosciences Co., Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jun Xian. Retrieved from https://idiyas.com/inventor/jun-xian-clx3szmg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jun Xian - Innovator in EZH2 Inhibition

Introduction

Jun Xian is a prominent inventor based in Southborough, MA (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific biological pathways. His work focuses on creating innovative solutions for diseases mediated by EZH2.

Latest Patents

Jun Xian holds a patent for a polysubstituted benzene compound and its preparation method and use. This invention provides a novel EZH2 inhibitor compound represented by formula (I). The compound is designed to prevent or treat diseases mediated by EZH2, showcasing Jun's commitment to advancing therapeutic options.

Career Highlights

Throughout his career, Jun has demonstrated a strong dedication to research and development. His work at Evopoint Biosciences Co., Ltd. has positioned him as a key player in the biotechnology sector. His innovative approach to drug design has garnered attention and respect within the scientific community.

Collaborations

Jun Xian collaborates with talented individuals such as Wei Peng and Yonghan Hu. These partnerships enhance the research environment and contribute to the successful development of new therapeutic strategies.

Conclusion

Jun Xian's contributions to the field of EZH2 inhibition exemplify the impact of innovative thinking in medicine. His work continues to pave the way for advancements in treating complex diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…